423 related articles for article (PubMed ID: 28359245)
1. The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
Rivero EM; Piñero CP; Gargiulo L; Entschladen F; Zänker K; Bruzzone A; Lüthy IA
Curr Cancer Drug Targets; 2017; 17(8):756-766. PubMed ID: 28359245
[TBL] [Abstract][Full Text] [Related]
2. Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation.
Pérez Piñero C; Bruzzone A; Sarappa MG; Castillo LF; Lüthy IA
Br J Pharmacol; 2012 May; 166(2):721-36. PubMed ID: 22122228
[TBL] [Abstract][Full Text] [Related]
3. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
4. The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.
Jabloñski M; Rodríguez MS; Rivero EM; Bruque CD; Vanzulli S; Bruzzone A; Pérez Piñero C; Lüthy IA
Cancer Chemother Pharmacol; 2023 Dec; 92(6):485-499. PubMed ID: 37725114
[TBL] [Abstract][Full Text] [Related]
5. Propranolol inhibits neonatal Nav1.5 activity and invasiveness of MDA-MB-231 breast cancer cells: Effects of combination with ranolazine.
Lee A; Fraser SP; Djamgoz MBA
J Cell Physiol; 2019 Dec; 234(12):23066-23081. PubMed ID: 31222761
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
7. Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells.
Awad AB; Williams H; Fink CS
Nutr Cancer; 2001; 40(2):157-64. PubMed ID: 11962251
[TBL] [Abstract][Full Text] [Related]
8. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Li M; Li P; Zhang M; Ma F
Chin J Integr Med; 2018 Jan; 24(1):40-46. PubMed ID: 28795388
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Aloe emodin on invasion and metastasis of high metastatic breast cancer MDA-MB-231 cells].
He ZH; Huang YQ; Weng SF; Tan YR; He TP; Qin YM; Liang NC
Zhong Yao Cai; 2013 Sep; 36(9):1481-5. PubMed ID: 24620697
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
He Q; Jing H; Liaw L; Gower L; Vary C; Hua S; Yang X
Sci Rep; 2016 Mar; 6():23216. PubMed ID: 26976794
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxy-1,4-Naphthoquinone (MNQ) suppresses the invasion and migration of a human metastatic breast cancer cell line (MDA-MB-231).
Liew K; Yong PV; Lim YM; Navaratnam V; Ho AS
Toxicol In Vitro; 2014 Apr; 28(3):335-9. PubMed ID: 24291160
[TBL] [Abstract][Full Text] [Related]
13. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
[TBL] [Abstract][Full Text] [Related]
14. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
15. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibition of the uPAR·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis.
Mani T; Wang F; Knabe WE; Sinn AL; Khanna M; Jo I; Sandusky GE; Sledge GW; Jones DR; Khanna R; Pollok KE; Meroueh SO
Bioorg Med Chem; 2013 Apr; 21(7):2145-55. PubMed ID: 23411397
[TBL] [Abstract][Full Text] [Related]
17. Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer.
Su W; Wang L; Zhou M; Liu Z; Hu S; Tong L; Liu Y; Fan Y; Kong D; Zheng Y; Han Z; Wu JC; Xiang R; Li Z
Cell Transplant; 2013; 22(11):2079-90. PubMed ID: 23067802
[TBL] [Abstract][Full Text] [Related]
18. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
19. Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells.
Bao L; Matsumura Y; Baban D; Sun Y; Tarin D
Br J Cancer; 1994 Aug; 70(2):228-32. PubMed ID: 8054270
[TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
